Search

Your search keyword '"Cooper, Laurence J.N."' showing total 346 results

Search Constraints

Start Over You searched for: Author "Cooper, Laurence J.N." Remove constraint Author: "Cooper, Laurence J.N."
346 results on '"Cooper, Laurence J.N."'

Search Results

1. Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses

2. Data from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells

3. Data from Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

4. Supplementary Movie 3 from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells

5. Supplementary Movie 5 from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells

6. Supplementary Movie 2 from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells

7. Supplementary Movie 4 from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells

8. Supplementary Movie 1 from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells

9. Supplemental Methods, Tables 1 - 3, Figures 1 - 16 from Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

10. Supplemental Table 1, Figures 1 - 20 from Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells

13. Supplementary Video D from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

15. Supplementary figure 5 from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

16. Tables 1 and 2 from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

17. Supplementary Video E from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

19. Supplementary figure 1 and 2 from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

20. Supplementary Materials and Methods, Figures 1 - 13, Table 1 from Activating and Propagating Polyclonal Gamma Delta T Cells with Broad Specificity for Malignancies

21. Supplementary materials from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

23. Supplementary Video A from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

25. Supplementary figure 3 and 4 from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

28. Supplementary Video C from Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma

29. Supplementary Figure 1 from Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies

30. Data from Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies

31. Supplementary Figure 2 from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

32. Supplementary Figure 5 from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

33. Supplementary Table 1 from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

34. Supplementary Materials and Methods from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

35. Supplementary Figure 4 from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

36. Data from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

37. Supplementary Table 2 from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

38. Supplementary Video 2 from Combining Adoptive Cellular and Immunocytokine Therapies to Improve Treatment of B-Lineage Malignancy

39. Supplementary Tables 1-5 from Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010

40. Supplementary References from Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010

41. Supplementary Figure 1 from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

42. Supplementary Figure 3 from Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

43. Supplementary Video 1 from Combining Adoptive Cellular and Immunocytokine Therapies to Improve Treatment of B-Lineage Malignancy

45. Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

47. Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

49. Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine

Catalog

Books, media, physical & digital resources